Endoscopy 2023; 55(12): 1083-1094
DOI: 10.1055/a-2129-5752
Systematic review

Cold snare endoscopic mucosal resection for colon polyps: a systematic review and meta-analysis

Autoren

  • Mohamed Abdallah

    1   Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota, United States
  • Khalid Ahmed

    2   Department of Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, Pennsylvania, United States
  • Daniyal Abbas

    3   Department of Internal Medicine, East Carolina University, Greenville, North Carolina, United States
  • Mouhand F. H. Mohamed

    4   Brown University, Warren Alpert Medical School, Providence, Rhode Island, United States
  • Gaurav Suryawanshi

    1   Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota, United States
  • Nicholas McDonald

    1   Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota, United States
  • Natalie Wilson

    1   Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota, United States
  • Shifa Umar

    5   Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States
  • Aasma Shaukat

    6   Division of Gastroenterology, Department of Medicine and Population Health, NYU Grossman School of Medicine, New York, New York, United States
  • Mohammad Bilal

    1   Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota, United States


Graphical Abstract

Abstract

Background Cold snare endoscopic mucosal resection (CS-EMR) can reduce the risks associated with electrocautery during colon polyp resection. Data on efficacy are variable. This systematic review and meta-analysis aimed to estimate the pooled efficacy and safety rates of CS-EMR.

Methods We conducted a comprehensive literature search of multiple databases, from inception to March 2023, for studies addressing outcomes of CS-EMR for colon polyps. The weighted pooled estimates with 95 %CIs were calculated using the random effects model. I2 statistics were used to evaluate heterogeneity.

Results 4137 articles were reviewed, and 16 studies, including 2592 polyps in 1922 patients (51.4 % female), were included. Overall, 54.4 % of polyps were adenomas, 45 % were sessile serrated lesions (SSLs), and 0.6 % were invasive carcinomas. Polyp recurrence after CS-EMR was 6.7 % (95 %CI 2.4 %–17.4 %, I2  = 94 %). The recurrence rate was 12.3 % (95 %CI 3.4 %–35.7 %, I2  = 94 %) for polyps ≥ 20 mm, 17.1 % (95 %CI 4.6 %–46.7 %, I2  = 93 %) for adenomas, and 5.7 % (95 %CI 3.2 %–9.9 %, I2  = 50 %) for SSLs. The pooled intraprocedural bleeding rate was 2.6 % (95 %CI 1.5 %–4.5 %, I2  = 51 %), the delayed bleeding rate was 1.5 % (95 %CI 0.8 %–2.7 %, I2  = 18 %), and no perforations or post-polypectomy syndromes were reported, with estimated rates of 0.6 % (95 %CI 0.3 %–1.3 %, I2  = 0 %) and 0.6 % (95 %CI 0.3 %–1.4 %, I2  = 0 %), respectively.

Conclusion CS-EMR demonstrated an excellent safety profile for colon polyps, with variable recurrence rates based on polyp size and histology. Large prospective studies are needed to validate these findings.



Publikationsverlauf

Eingereicht: 01. Februar 2023

Angenommen nach Revision: 14. Juli 2023

Accepted Manuscript online:
14. Juli 2023

Artikel online veröffentlicht:
22. September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany